Moomoo AI 已提取核心信息
Assembly Biosciences, Inc. (ASMB) has announced a reverse stock split that is scheduled to take effect before the market opens on February 12, 2024. The split will be conducted on a 1-for-12 basis, meaning that each common share of ASMB will be converted into the right to receive approximately 0.083333 new common shares of Assembly Biosciences. Shareholders will receive cash in lieu of fractional shares that result from the split. Concurrently, the option symbol for Assembly Biosciences will change from ASMB to ASMB1. The new CUSIP number for the post-split shares will be 045396207. The cash in lieu amount for fractional shares will be determined and settled through the National Securities Clearing Corporation (NSCC), with the Options Clearing Corporation (OCC) delaying settlement of the cash portion until the amount is finalized. The OCC will then require put exercisers and call assignees to deliver the appropriate cash amount.
Assembly Biosciences, Inc. (ASMB) has announced a reverse stock split that is scheduled to take effect before the market opens on February 12, 2024. The split will be conducted on a 1-for-12 basis, meaning that each common share of ASMB will be converted into the right to receive approximately 0.083333 new common shares of Assembly Biosciences. Shareholders will receive cash in lieu of fractional shares that result from the split. Concurrently, the option symbol for Assembly Biosciences will change from ASMB to ASMB1. The new CUSIP number for the post-split shares will be 045396207. The cash in lieu amount for fractional shares will be determined and settled through the National Securities Clearing Corporation (NSCC), with the Options Clearing Corporation (OCC) delaying settlement of the cash portion until the amount is finalized. The OCC will then require put exercisers and call assignees to deliver the appropriate cash amount.
Assembly Biosciences, Inc.（ASMB）宣布了反向股票拆分，计划于2024年2月12日市场开盘前生效。拆分将以1比12的方式进行，这意味着ASMB的每股普通股将转换为获得约0.083333股Assembly Biosciences新普通股的权利。股东将获得现金来代替拆分产生的部分股份。同时，Assembly Biosciences的期权符号将从ASMB更改为 ASMB1。拆分后股票的新CUSIP号码将为045396207。部分股份的现金替代金额将通过国家证券清算公司（NSCC）确定和结算，期权清算公司（OCC）将现金部分的结算推迟到金额最终确定之后。然后，OCC将要求看跌期权使用者和看涨受让人提供适当的现金金额。
Assembly Biosciences, Inc.（ASMB）宣布了反向股票拆分，计划于2024年2月12日市场开盘前生效。拆分将以1比12的方式进行，这意味着ASMB的每股普通股将转换为获得约0.083333股Assembly Biosciences新普通股的权利。股东将获得现金来代替拆分产生的部分股份。同时，Assembly Biosciences的期权符号将从ASMB更改为 ASMB1。拆分后股票的新CUSIP号码将为045396207。部分股份的现金替代金额将通过国家证券清算公司（NSCC）确定和结算，期权清算公司（OCC）将现金部分的结算推迟到金额最终确定之后。然后，OCC将要求看跌期权使用者和看涨受让人提供适当的现金金额。
有用
没用
该公告为独立文件：